Posts in Podcasts

In a globalized economy, it’s essential to understand that patents are still nationalized documents. For example, a U.S. patent only grants the right to exclude others from making, using, selling, and importing the claimed invention within the United States. It has no bearing on activities in Europe, Canada, Mexico, China, or anywhere else in the world. To restrict activities there, you will typically need a patent granted in each relevant country. This can boil down to filing and prosecution on a per-country basis. However, those seeking protection in Europe do have some additional options for a single application granting protection in multiple nations!

In our latest IPWatchdog Unleashed podcast, I spoke with Rob Sahr, shareholder at Wolf Greenfield and co-chair of our 2025 Life Sciences Masters™ program. Our conversation zeroed in on a hard truth the public rarely sees: moving a molecule from early discovery to an FDA-approved therapy requires a chain of scientific and economic miracles—and every one of them leans on a reliable patent system. In this conversation we discuss the extraordinary journey from molecule to medicine. Together, we explore how scientific breakthroughs depend not only on research and capital, but also on a stable and predictable patent system. From double patenting and government funding to judicial uncertainty and policy headwinds, our conversation dives into the fragile balance between innovation and patent policy—and the many scientific miracles required to bring new drugs to life.

Artificial intelligence (AI), viewed from an optimist’s perspective, is an accelerant for humans; a tool to handle tedious tasks that allow users to spend more time and energy on what really matters. On the current episode of Understanding IP Matters (UIPM), Eric Bear, a classically-trained actor, singer and dancer, and now a kinesthetic artist specializing in primate motion capture, discusses the interplay of creativity and technology. Bear is a successful entrepreneur, industry expert and inventor responsible for more than 100 patents.

In our latest IPWatchdog Unleashed podcast, we had a riveting and sometimes emotional conversation that unfolded around one of the most pressing issues in life sciences today: the journey of life-saving drugs from laboratory to patient. We discuss the pivotal role a strong patent system plays in this important journey with guest Sherry Knowles. Sherry is the founder of Knowles Intellectual Property Strategies and former Senior Vice President and Chief Patent Counsel for GlaxoSmithKline. In addition to being one of the leading voices in the life sciences and patent industries, Sherry is also a cancer survivor. Among other things we discuss numerous patent system challenges facing innovator drug companies, the downward pressure generic drugs place on the industry and leading to important drugs becoming unavailable, the role of Pharmacy Benefit Managers (PBMs) with respect to significantly raising the cost of drugs for Americans, and policy influences and legislation on Capitol Hill. Sherry also shares her personal story and insights into why patents are more than just legal constructs—they are deeply personal lifelines.

In the latest episode of IP Innovators, host Steve Brachmann discusses the evolution of patent practice, in-house innovation, and the growing role of AI with Phil Harris, Equity Partner and Patent Practice Group Leader at Holland & Hart. As firms navigate when to build their own tools versus partnering with vendors, Harris offers a grounded look at how automation is reshaping the daily realities of patent work, and why the most forward-thinking teams treat innovation not as a one-time project, but as a continuous practice.

For many guitarists, finding the right tone is a lifelong pursuit. It’s the quest for the perfect sound—a sound controlled not only by the guitar or the amplifier but also by the complex chain of electronics connecting them. Central to this are the effects pedals, and few pedals have the same mythical status as the Klon Centaur. This legendary pedal, built by guitarist and designer Bill Finnegan in the 1990s, was the subject of a recent trademark lawsuit that drew a line between a respectful “klone” (often spelled with a “K”) and an infringing counterfeit.

On the current episode of Understanding IP Matters (UIPM), Ruth Vitale, Hollywood producer, founder and co-president of Paramount Classics, and president of Fine Line Features, discusses her efforts to effect U.S. legislation that would allow for site blocking, thereby strengthening the entertainment industry and protecting U.S. consumers. As the entertainment industry is a top cultural exporter in the United States, this added protection and greater retained revenue would ensure this status continues and grows.

This week on IPWatchdog Unleashed we tackle the impact of tariffs and geopolitical uncertainty on intellectual property (IP) strategy, budgets and patent portfolios.  In today’s fast-paced global economy, intellectual property (IP) teams face unprecedented challenges and opportunities. The world is witnessing a flux of geopolitical tensions, economic uncertainties, and rapid technological advancements, all of which demand agility and strategic foresight from IP professionals. Meanwhile, to complicate matters the United States is attempting to rearrange international business norms by diversifying supply chains for particularly important goods and components, while simultaneously aggressively using tariffs to change global economic behavior and settle international conflicts and wars. There is no doubt that this is a tumultuous time for all businesses, which demands attention, forethought and deliberate strategic action.

In the third episode of IP Innovators, host Steve Brachmann sits down with Mark Kesslen, Partner and Chair of the Intellectual Property Group at Lowenstein Sandler, to trace a career that spans from the dawn of online banking and the FinTech revolution to the rise of AI in patent law. As AI tools become increasingly common in law firms and patent practices across the United States, Kesslen offers a firsthand view of how attorneys are learning to integrate these systems effectively and responsibly. From his early work digitizing finance at LabMorgan to leading AI adoption in a top-tier IP practice, Kesslen’s story reflects a profession once again at a turning point defined by the mantra: “Trust, but verify.”

This week on IPWatchdog Unleashed we tackle the impact of tariffs and geopolitical uncertainty on intellectual property (IP) strategy, budgets and patent portfolios.  In today’s fast-paced global economy, intellectual property (IP) teams face unprecedented challenges and opportunities. The world is witnessing a flux of geopolitical tensions, economic uncertainties, and rapid technological advancements, all of which demand agility and strategic foresight from IP professionals. Meanwhile, to complicate matters the United States is attempting to rearrange international business norms by diversifying supply chains for particularly important goods and components, while simultaneously aggressively using tariffs to change global economic behavior and settle international conflicts and wars. There is no doubt that this is a tumultuous time for all businesses, which demands attention, forethought and deliberate strategic action.

The value of intellectual property (IP) rights has decreased in the United States over the past 20 years because large tech companies consider patents and copyrights an enemy, not an ally, and because of the difficulty SMEs and independent creators have generating sufficient economic return. But when different stakeholder groups come together, they can develop an equitable and inclusive IP system that moves society forward while supporting their respective business agendas. These are the beliefs of Daryl Lim, a leader in understanding the global IP community.

This week on IPWatchdog Unleashed, I explored the complex, fascinating and scandalous world of counterfeits, dupes and fakes with my guest, Gina Johnson, Chief Legal Officer of Ridge Wallet. Johnson shared her experiences and insights into fighting the never-ending onslaught of copycats and nefarious actors. Sadly, a successful company with a desirable product and brand must constantly remain vigilant to exclusively sell its products online, even when it has intellectual property that should offer protection against such flagrant violations.

On Friday, October 10, we hosted an impromptu webinar with the intention of using that conversation as our next podcast. While this is not always feasible, because we do often have PowerPoint slides when we host webinars, this webinar was simply a conversation about a very important recent decision of the Unified Patent Court (UPC) without any slides. The case we discuss is Philips v. Belkin, where after the conclusion of all appeals, the UPC issued the first ever final permanent injunction in a case involving standard essential patents (SEPs). So, our conversation this week is about the impact and ramifications of the UPC’s final decision in Philips v. Belkin. We discussed the UPC’s final decision and permanent injunction in Philips v. Belkin with an in-house attorney from Philips and the litigation team at Bardehle Pagenberg in Germany that represented Philips in this important win. By originally having this conversation as a webinar with a live audience, I was able to incorporate questions from the audience, which you’ll hear periodically throughout the podcast.

The U.S. patent system is facing challenges from many stakeholders, including from groups that believe a weak patent system will result in lower drug prices and more widely available treatments. Such a system would have the opposite effect: fewer treatments being developed due to less research dollars spent. Research and development, and subsequently new drug products, will not occur without a meaningful patent system to provide a level of certainty that investments can be recovered.

This week on IPWatchdog Unleashed, I speak with Dana Colarulli, who is a partner at ACG Advocacy—one of the premiere intellectual property lobby firms in Washington, DC. During our conversation we delve into the intricate world of patent policy and politics, discussing laws, the dynamic environment at the USPTO. Dana shares his extensive experience and insights on high-growth technology businesses. We address critical topics such as the recent shake-ups at the USPTO, the controversial “patent tax” proposal, how despite the fact that the USPTO is user-fee funded it is being swept up in broader Trump Administration efforts to downsize the federal government, what the word “innovation” really means, how businesses use intellectual property assets, the importance of predictable IP assets, the challenges of effective patent valuation, international collaboration and education to support small and medium size enterprises (SMEs), and much more.